And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

Intellia Therapeutics is featured in Cathie Wood's portfolio and has a high Wall Street price target. The company's leading candidates look somewhat promising, but one of them just hit a major setback ...

Healthcare stocks in the S&P 500 are up just 4.8% for the year, compared to the S&P 500's 15.9% gain.

Goldman Sachs is also bullish on the growth of this market. The Wall Street firm's "base-case" estimate is for 1.4 million shipments of humanoids by 2035. Its "bull-case" projects unit shipments to ...

Any list of top AI stocks has to start with the biggest of the bunch, Nvidia ( NVDA 2.00%). Nvidia's share in the data center graphics processing unit (GPU) market is more than 90%, helping it to ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...

A record 1,434 individuals, each with a net worth of more than US$700 million, have made it onto Hurun's list of China's richest people ...

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Duopharma Biotech Berhad (KLSE:DPHARMA) as an investment opportunity by projecting its future cash ...

Dyne Therapeutics (NASDAQ: DYN) had a Monday neither it nor its investors will ever forget. This wasn't of its own making, ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...